Business

Synthaverse Signs Deal With Blau Farmaceutica For BCG 10 Vaccine

Synthaverse Signs Deal With Blau Farmaceutica For BCG 10 Vaccine

Synthaverse Spolka AkcyjnaSeptember 29, 20255
Synthaverse Signs Deal With Blau Farmaceutica For BCG 10 Vaccine

About this update from Synthaverse Spolka Akcyjna

Synthaverse SA GPW:SVE:SIGNS AGREEMENT WITH BLAU FARMACEUTICA FOR BCG 10 VACCINEMINIMUM TOTAL ORDER VALUE SET AT 76.3 MILLION ZLOTYSDEAL FOR SALE AND DISTRIBUTION OF BCG 10 VACCINE

View stock analysis, news, and events for Synthaverse Spolka Akcyjna